Elevance Health, Inc. vs Abbvie Inc.
ELV vs ABBV — side-by-side comparison from reported financials. ELV leads 6, ABBV leads 6 of 12 comparable metrics.
Elevance Health, Inc.
ELV · Healthcare
$411.70+2.68%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ELV | ABBV |
|---|---|---|
| Price | $411.70 | $276.43 |
| Market cap | $89.3B | $488B |
| Revenue (TTM) | $201B | $64.4B |
| Revenue growth | +8.3% | +1.8% |
| Net margin | 2.5% | 9.8% |
| Free cash flow | $6.29B | $18.2B |
| Net cash (debt) | $4.43B | ($56.2B) |
| 1-year price return | +15.0% | +19.8% |
| P/E | 18.0 | 77.4 |
| P/E vs own history (cheap-side %) | 48% | 23% |
| Dividend yield | 1.68% | 2.45% |
| Return on equity | 11% | 96% |
| Altman Z-score | 1.33 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 97,100 | 57,000 |
Full résumé-style profiles: ELV CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.